Management of patients with infective endocarditis: current state-of-art. Part II: treatment, prevention
Б. С. Белов(Association of Rheumatologists of Russia), N. V. Muravyova(Association of Rheumatologists of Russia), Г. М. Тарасова(Association of Rheumatologists of Russia)
Cited by 1
Related Papers
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
|Rheumatology Science and Practice|2021|54
COVID-19: the new challenge for rheumatologists
|Modern Rheumatology Journal|2020|30
Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)
|Meditsinskiy sovet = Medical Council|2019|14
Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review
|Rheumatology Science and Practice|2021|14
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
|Rheumatology Science and Practice|2022|13